mPOR company originates from the Laboratory of Biocybernetics of the Faculty of Electrical Engineering, University of Ljubljana. Their business idea is the HF-EP high-frequency electroporator, which works on the principle of electroporation - a method that temporarily increases the permeability of cell membranes using electrical pulses. It can be used by experts to deliver active substances into the cell (chemotherapy), DNA (gene therapy) and locally induce cell death (ablation).

The electroporators currently on the market generate 100 μs-100 ms pulses, which are very uncomfortable and often painful for patients due to the irritation of pain receptors and muscle contraction. The mPOR company has thus performed the world's first human study confirming that high-frequency 1-3 μs bipolar pulses significantly reduce muscle contraction and pain.

Their product has been used since the first prototype in the Biocybernetics laboratory and the Oncology Institute.

In 2022, mPOR was the finalist for Slovenian Startup of the Year award!